Health Care

Biosimilar Net Spending on Biologic Medicines 2014 to 2018 in billions

Biosimilar benefits (access required)

Biosimilars could generate savings of about $116 million in New Jersey annually—including the state’s Medicaid program and patients with commercial insurance, according to a new issue brief by the Center for Medical Economics and Innovation at the Pacific Research Institute. Nationwide, those annual savings could reach $7 billion.

Read More »

New Jersey families challenged to help knock out opioid abuse

Communities from across the state will participate in the 11th annual American Medicine Chest Challenge – New Jersey Day of Awareness of Prescription Drug Abuse and Safe Disposal, a public health initiative from the Partnership for a Drug-Free New Jersey designed to help raise awareness about the dangers of prescription drug abuse.

Read More »